Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
7th April 2026 Uncategorised 0
Subcutaneous delivery shows IV‑level efficacy in moderate to severe TED

More: Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
Source: News
